Implant Sciences Corporation Continues Operational Streamlining
WAKEFIELD, Mass.--(BUSINESS WIRE)--Implant Sciences Corporation (AMEX: IMX) announced that as of Friday, June 29, 2007, it had completed the first phase of its plans for exiting the radioactive prostate seeds business, which included a major reduction of staffing in this business segment. Additionally, the Company announced it has reduced the size of its employee base in other areas of activity.